PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Advanced Science3 citationsOpen Access

Iron Oxide Nanozyme as Reactive Oxygen and Nitrogen Species Scavenger to Regulate Microglial Homeostasis in Stroke

View Full Paper
YQYilin QiCWChunxiao WangXHXin Hu

Key Points

  • The aim is to investigate the effectiveness of iron oxide nanoparticles in scavenging reactive species and regulating microglial polarization post-stroke.
  • Utilization of iron oxide nanoparticles (IONP6) with enzyme-like activities to scavenge nitric oxide (NO).
  • In vitro studies under oxygen and glucose deprivation (OGD) conditions.
  • In vivo assessments using middle cerebral artery occlusion (pMCAO) stroke models.
  • Evaluation of the modulation of HIF-1α/TIM-3 signaling axis.
  • Comparison of infarct size and neurological outcomes before and after IONP6 administration.
  • IONP6 effectively scavenges nitric oxide, reducing its levels in stroke models.
  • IONP6 promotes microglial polarization towards the anti-inflammatory M2 phenotype.
  • Significant reduction in infarct size observed in treated stroke rats.
  • Improvement in neurological function following IONP6 treatment.

Abstract

ABSTRACT In ischemic stroke, microglia adopt a pro–inflammatory M1‐like phenotype, which plays a pivotal role in the excessive production of nitric oxide radical (NO). The elevated levels of NO contribute to caspase‐mediated apoptosis, resulting in significant disruption of cerebral tissue architecture and consequent loss of brain function. In this study, we demonstrate that iron oxide nanoparticles (IONPs) with intrinsic enzyme–like activities can effectively scavenge NO by forming a nitrosyl‐metal complex. Specifically, 6 nm iron oxide nanoparticle (IONP6) exhibits enzyme‐like activities, superoxide dismutase (SOD) and catalase (CAT), thus potentially possessing the ability to scavenge the Reactive Oxygen and Nitrogen Species (RONS), especially the ability to scavenge NO. Furthermore, we show that IONP6 promotes the polarization of microglia toward the M2 phenotype, thereby alleviating neuroinflammation in both in vitro oxygen and glucose deprivation (OGD) and in vivo permanent middle cerebral artery occlusion (pMCAO) stroke models. This is achieved through the modulation of the HIF‐1α/TIM‐3 signaling axis in stroke rats. Additionally, IONP6 administration significantly reduces infarct size and improves neurological outcomes in stroke rats. Our findings position IONP6 as a promising drug‐free therapeutic agent for stroke, capable of regulating microglial polarization and mitigating secondary injury caused by the inflammatory cascade induced by NO.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Qi et al. (2026) studied this question.

synapsesocial.com/papers/6971bd4c642b1836717e1fa5https://doi.org/10.1002/advs.202518191
Ask AI
Helpful
Bookmark
Share
View Full Paper